Novo Nordisk Receivables 2010-2024 | NVO

Novo Nordisk receivables for the quarter ending December 31, 2024 were $12.675B, a 15.99% increase year-over-year.

  • Novo Nordisk receivables for 2024 were $12.675B, a 15.99% increase from 2023.
  • Novo Nordisk receivables for 2023 were $10.928B, a 34.2% increase from 2022.
  • Novo Nordisk receivables for 2022 were $8.143B, a 9.36% increase from 2021.

Novo Nordisk Receivables 2010-2024 | NVO

  • Novo Nordisk receivables for 2024 were $12.675B, a 15.99% increase from 2023.
  • Novo Nordisk receivables for 2023 were $10.928B, a 34.2% increase from 2022.
  • Novo Nordisk receivables for 2022 were $8.143B, a 9.36% increase from 2021.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$827.9B
Johnson & Johnson (JNJ)$384.4B
AbbVie (ABBV)$354.6B
Roche Holding AG (RHHBY)$262.5B
Merck (MRK)$221.8B
Novartis AG (NVS)$219.3B
Pfizer (PFE)$146.8B
Sanofi (SNY)$137.4B
Bayer (BAYRY)$22.6B
Innoviva (INVA)$1.1B